International Conference on Pharmacy, Classification of Drugs and Drug Action (ICPCLDDA - 27)

This track will explore the latest developments in pharmacology, focusing on drug action mechanisms and their therapeutic implications. Researchers are encouraged to present studies that elucidate the pharmacodynamics and pharmacokinetics of new and existing drugs.

This session will highlight novel approaches in medicinal chemistry, including drug design and synthesis. Participants will discuss the impact of chemical structures on drug efficacy and safety profiles.

This track will examine the role of clinical pharmacology in enhancing patient outcomes through personalized medicine. Presentations will focus on direct-patient care strategies and the integration of pharmacological knowledge into clinical practice.

This session will delve into the pharmacological effects on the nervous system, including the mechanisms of action of psychoactive substances. Researchers will share insights on the therapeutic and adverse effects of drugs on mental health.

This track will address the safety profiles of pharmaceutical drugs, focusing on toxicological assessments and risk evaluation. Presentations will include studies on drug toxicity and the identification of adverse drug reactions.

This session will explore the role of laboratory medicine in drug discovery and patient diagnostics. Participants will discuss advancements in molecular diagnostics and their applications in pharmacotherapy.

This track will focus on the evolving role of pharmacy practice in improving health outcomes. Discussions will include the integration of pharmacists in healthcare teams and their impact on medication management.

This session will highlight the intersection of chemical biology and pharmacology, emphasizing the biochemical mechanisms underlying drug action. Researchers will present findings on the interactions between drugs and biological systems.

This track will investigate new drug classes and their therapeutic applications in various medical fields. Presentations will cover the classification, mechanism of action, and clinical implications of these emerging therapies.

This session will focus on the molecular and cellular mechanisms that govern drug action and efficacy. Researchers are invited to present studies that elucidate the signaling pathways and biological responses to pharmacological agents.

This track will address the ethical challenges faced in pharmacy practice and medical research. Discussions will include informed consent, the placebo effect, and the moral implications of drug development and distribution.